comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 00:46:52 - browse：9264

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Annovis Bio delivers candor, but not confidence, on Parkinson’s study

WSS

Intellia plays down concerns on accidental germline transmission

Intellia plays down concerns on accidental germline transmission

New documents shed light on MD Anderson Cancer Institute feud

New documents shed light on MD Anderson Cancer Institute feud

A solution to the after

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

hotspot

comprehensive

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Supreme Court strikes down use of affirmative action

How to make over

State Dept. review finds Biden bears some blame for Afghanistan failures

Health officials lay out plans to cope with respiratory virus season

Medicare details structure of new drug price negotiation program

Intellia plays down concerns on accidental germline transmission

Malaria cases in Florida and Texas: Here’s what you need to know

National associations that represent hospice owe an apology

hotspot

Why palliative psychiatry is worth discussing

Meadows told special counsel he could not recall Trump ever declassifying Mar

Former Pear Therapeutics executives start new VC firm

New documents shed light on MD Anderson Cancer Institute feud

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

A new nitrogen execution bill also undermines medical licensing

Wikipedia

focus

hotspot

focus